Associations Between Hypoglycemia Awareness Status and Symptoms of Hypoglycemia Among Adults with Type 1 or Insulin-Treated Type 2 Diabetes Using the Hypo-METRICS Smartphone Application

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

Associations Between Hypoglycemia Awareness Status and Symptoms of Hypoglycemia Among Adults with Type 1 or Insulin-Treated Type 2 Diabetes Using the Hypo-METRICS Smartphone Application. / Martine-Edith, Gilberte; Zaremba, Natalie; Divilly, Patrick; Søholm, Uffe; Broadley, Melanie; Baumann, Petra Martina; Mahmoudi, Zeinab; Gomes, Mikel; Ali, Namam; Abbink, Evertine J.; de Galan, Bastiaan; Brøsen, Julie; Pedersen-Bjergaard, Ulrik; Vaag, Allan A.; McCrimmon, Rory J.; Renard, Eric; Heller, Simon; Evans, Mark; Cigler, Monika; Mader, Julia K.; Amiel, Stephanie A.; Speight, Jane; Pouwer, Frans; Choudhary, Pratik; for the Hypo-RESOLVE Consortium.

I: Diabetes Technology and Therapeutics, 2024.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Martine-Edith, G, Zaremba, N, Divilly, P, Søholm, U, Broadley, M, Baumann, PM, Mahmoudi, Z, Gomes, M, Ali, N, Abbink, EJ, de Galan, B, Brøsen, J, Pedersen-Bjergaard, U, Vaag, AA, McCrimmon, RJ, Renard, E, Heller, S, Evans, M, Cigler, M, Mader, JK, Amiel, SA, Speight, J, Pouwer, F, Choudhary, P & for the Hypo-RESOLVE Consortium 2024, 'Associations Between Hypoglycemia Awareness Status and Symptoms of Hypoglycemia Among Adults with Type 1 or Insulin-Treated Type 2 Diabetes Using the Hypo-METRICS Smartphone Application', Diabetes Technology and Therapeutics. https://doi.org/10.1089/dia.2023.0596

APA

Martine-Edith, G., Zaremba, N., Divilly, P., Søholm, U., Broadley, M., Baumann, P. M., Mahmoudi, Z., Gomes, M., Ali, N., Abbink, E. J., de Galan, B., Brøsen, J., Pedersen-Bjergaard, U., Vaag, A. A., McCrimmon, R. J., Renard, E., Heller, S., Evans, M., Cigler, M., ... for the Hypo-RESOLVE Consortium (2024). Associations Between Hypoglycemia Awareness Status and Symptoms of Hypoglycemia Among Adults with Type 1 or Insulin-Treated Type 2 Diabetes Using the Hypo-METRICS Smartphone Application. Diabetes Technology and Therapeutics. https://doi.org/10.1089/dia.2023.0596

Vancouver

Martine-Edith G, Zaremba N, Divilly P, Søholm U, Broadley M, Baumann PM o.a. Associations Between Hypoglycemia Awareness Status and Symptoms of Hypoglycemia Among Adults with Type 1 or Insulin-Treated Type 2 Diabetes Using the Hypo-METRICS Smartphone Application. Diabetes Technology and Therapeutics. 2024. https://doi.org/10.1089/dia.2023.0596

Author

Martine-Edith, Gilberte ; Zaremba, Natalie ; Divilly, Patrick ; Søholm, Uffe ; Broadley, Melanie ; Baumann, Petra Martina ; Mahmoudi, Zeinab ; Gomes, Mikel ; Ali, Namam ; Abbink, Evertine J. ; de Galan, Bastiaan ; Brøsen, Julie ; Pedersen-Bjergaard, Ulrik ; Vaag, Allan A. ; McCrimmon, Rory J. ; Renard, Eric ; Heller, Simon ; Evans, Mark ; Cigler, Monika ; Mader, Julia K. ; Amiel, Stephanie A. ; Speight, Jane ; Pouwer, Frans ; Choudhary, Pratik ; for the Hypo-RESOLVE Consortium. / Associations Between Hypoglycemia Awareness Status and Symptoms of Hypoglycemia Among Adults with Type 1 or Insulin-Treated Type 2 Diabetes Using the Hypo-METRICS Smartphone Application. I: Diabetes Technology and Therapeutics. 2024.

Bibtex

@article{b36b1831fa23429db812af24d7652fb6,
title = "Associations Between Hypoglycemia Awareness Status and Symptoms of Hypoglycemia Among Adults with Type 1 or Insulin-Treated Type 2 Diabetes Using the Hypo-METRICS Smartphone Application",
abstract = "Introduction: This study examined associations between hypoglycemia awareness status and hypoglycemia symptoms reported in real-time using the novel Hypoglycaemia—MEasurement, ThResholds and ImpaCtS (Hypo-METRICS) smartphone application (app) among adults with insulin-treated type 1 (T1D) or type 2 diabetes (T2D). Methods: Adults who experienced at least one hypoglycemic episode in the previous 3 months were recruited to the Hypo-METRICS study. They prospectively reported hypoglycemia episodes using the app for 10 weeks. Any of eight hypoglycemia symptoms were considered present if intensity was rated between “A little bit” to “Very much” and absent if rated “Not at all.” Associations between hypoglycemia awareness (as defined by Gold score) and hypoglycemia symptoms were modeled using mixed-effects binary logistic regression, adjusting for glucose monitoring method and diabetes duration. Results: Of 531 participants (48% T1D, 52% T2D), 45% were women, 91% white, and 59% used Flash or continuous glucose monitoring. Impaired awareness of hypoglycemia (IAH) was associated with lower odds of reporting autonomic symptoms than normal awareness of hypoglycemia (NAH) (T1D odds ratio [OR] 0.43 [95% confidence interval {CI} 0.25-0.73], P = 0.002); T2D OR 0.51 [95% CI 0.26-0.99], P = 0.048), with no differences in neuroglycopenic symptoms. In T1D, relative to NAH, IAH was associated with higher odds of reporting autonomic symptoms at a glucose concentration <54 than >70 mg/dL (OR 2.18 [95% CI 1.21-3.94], P = 0.010). Conclusion: The Hypo-METRICS app is sensitive to differences in hypoglycemia symptoms according to hypoglycemia awareness in both diabetes types. Given its high ecological validity and low recall bias, the app may be a useful tool in research and clinical settings. The clinical trial registration number is NCT04304963.",
keywords = "Hypo-METRICS, Hypoglycemia awareness, Hypoglycemia symptoms",
author = "Gilberte Martine-Edith and Natalie Zaremba and Patrick Divilly and Uffe S{\o}holm and Melanie Broadley and Baumann, {Petra Martina} and Zeinab Mahmoudi and Mikel Gomes and Namam Ali and Abbink, {Evertine J.} and {de Galan}, Bastiaan and Julie Br{\o}sen and Ulrik Pedersen-Bjergaard and Vaag, {Allan A.} and McCrimmon, {Rory J.} and Eric Renard and Simon Heller and Mark Evans and Monika Cigler and Mader, {Julia K.} and Amiel, {Stephanie A.} and Jane Speight and Frans Pouwer and Pratik Choudhary and {for the Hypo-RESOLVE Consortium}",
note = "Publisher Copyright: Copyright 2024, Mary Ann Liebert, Inc., publishers.",
year = "2024",
doi = "10.1089/dia.2023.0596",
language = "English",
journal = "Diabetes Technology & Therapeutics",
issn = "1520-9156",
publisher = "Mary AnnLiebert, Inc. Publishers",

}

RIS

TY - JOUR

T1 - Associations Between Hypoglycemia Awareness Status and Symptoms of Hypoglycemia Among Adults with Type 1 or Insulin-Treated Type 2 Diabetes Using the Hypo-METRICS Smartphone Application

AU - Martine-Edith, Gilberte

AU - Zaremba, Natalie

AU - Divilly, Patrick

AU - Søholm, Uffe

AU - Broadley, Melanie

AU - Baumann, Petra Martina

AU - Mahmoudi, Zeinab

AU - Gomes, Mikel

AU - Ali, Namam

AU - Abbink, Evertine J.

AU - de Galan, Bastiaan

AU - Brøsen, Julie

AU - Pedersen-Bjergaard, Ulrik

AU - Vaag, Allan A.

AU - McCrimmon, Rory J.

AU - Renard, Eric

AU - Heller, Simon

AU - Evans, Mark

AU - Cigler, Monika

AU - Mader, Julia K.

AU - Amiel, Stephanie A.

AU - Speight, Jane

AU - Pouwer, Frans

AU - Choudhary, Pratik

AU - for the Hypo-RESOLVE Consortium

N1 - Publisher Copyright: Copyright 2024, Mary Ann Liebert, Inc., publishers.

PY - 2024

Y1 - 2024

N2 - Introduction: This study examined associations between hypoglycemia awareness status and hypoglycemia symptoms reported in real-time using the novel Hypoglycaemia—MEasurement, ThResholds and ImpaCtS (Hypo-METRICS) smartphone application (app) among adults with insulin-treated type 1 (T1D) or type 2 diabetes (T2D). Methods: Adults who experienced at least one hypoglycemic episode in the previous 3 months were recruited to the Hypo-METRICS study. They prospectively reported hypoglycemia episodes using the app for 10 weeks. Any of eight hypoglycemia symptoms were considered present if intensity was rated between “A little bit” to “Very much” and absent if rated “Not at all.” Associations between hypoglycemia awareness (as defined by Gold score) and hypoglycemia symptoms were modeled using mixed-effects binary logistic regression, adjusting for glucose monitoring method and diabetes duration. Results: Of 531 participants (48% T1D, 52% T2D), 45% were women, 91% white, and 59% used Flash or continuous glucose monitoring. Impaired awareness of hypoglycemia (IAH) was associated with lower odds of reporting autonomic symptoms than normal awareness of hypoglycemia (NAH) (T1D odds ratio [OR] 0.43 [95% confidence interval {CI} 0.25-0.73], P = 0.002); T2D OR 0.51 [95% CI 0.26-0.99], P = 0.048), with no differences in neuroglycopenic symptoms. In T1D, relative to NAH, IAH was associated with higher odds of reporting autonomic symptoms at a glucose concentration <54 than >70 mg/dL (OR 2.18 [95% CI 1.21-3.94], P = 0.010). Conclusion: The Hypo-METRICS app is sensitive to differences in hypoglycemia symptoms according to hypoglycemia awareness in both diabetes types. Given its high ecological validity and low recall bias, the app may be a useful tool in research and clinical settings. The clinical trial registration number is NCT04304963.

AB - Introduction: This study examined associations between hypoglycemia awareness status and hypoglycemia symptoms reported in real-time using the novel Hypoglycaemia—MEasurement, ThResholds and ImpaCtS (Hypo-METRICS) smartphone application (app) among adults with insulin-treated type 1 (T1D) or type 2 diabetes (T2D). Methods: Adults who experienced at least one hypoglycemic episode in the previous 3 months were recruited to the Hypo-METRICS study. They prospectively reported hypoglycemia episodes using the app for 10 weeks. Any of eight hypoglycemia symptoms were considered present if intensity was rated between “A little bit” to “Very much” and absent if rated “Not at all.” Associations between hypoglycemia awareness (as defined by Gold score) and hypoglycemia symptoms were modeled using mixed-effects binary logistic regression, adjusting for glucose monitoring method and diabetes duration. Results: Of 531 participants (48% T1D, 52% T2D), 45% were women, 91% white, and 59% used Flash or continuous glucose monitoring. Impaired awareness of hypoglycemia (IAH) was associated with lower odds of reporting autonomic symptoms than normal awareness of hypoglycemia (NAH) (T1D odds ratio [OR] 0.43 [95% confidence interval {CI} 0.25-0.73], P = 0.002); T2D OR 0.51 [95% CI 0.26-0.99], P = 0.048), with no differences in neuroglycopenic symptoms. In T1D, relative to NAH, IAH was associated with higher odds of reporting autonomic symptoms at a glucose concentration <54 than >70 mg/dL (OR 2.18 [95% CI 1.21-3.94], P = 0.010). Conclusion: The Hypo-METRICS app is sensitive to differences in hypoglycemia symptoms according to hypoglycemia awareness in both diabetes types. Given its high ecological validity and low recall bias, the app may be a useful tool in research and clinical settings. The clinical trial registration number is NCT04304963.

KW - Hypo-METRICS

KW - Hypoglycemia awareness

KW - Hypoglycemia symptoms

U2 - 10.1089/dia.2023.0596

DO - 10.1089/dia.2023.0596

M3 - Journal article

C2 - 38512385

AN - SCOPUS:85190730045

JO - Diabetes Technology & Therapeutics

JF - Diabetes Technology & Therapeutics

SN - 1520-9156

ER -

ID: 389907606